$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the uses, efficacy and clinical manifestations of Shafinamide Tablets (Siddaco) in patients with Parkinson's disease
2026-02-01 22:25:32
Check Details
Analysis of Tarlatamab-Imdelltra side effects, medication safety, and long-term use precautions
2026-02-01 22:25:32
Check Details
Telisotuzumab-EMRELIS contraindications and risks and limitations that patients should be aware of before use
2026-02-01 22:25:32
Check Details
What are the generic drugs of tovorafenib and their brand differences, market prices and reference instructions for use?
2026-02-01 22:25:32
Check Details
Is vorasidenib-VORANIGO an oral drug, how to use it, and patient precautions when taking the drug
2026-02-01 22:25:32
Check Details
Summary and analysis of the efficacy and clinical research of Zongatinib (Zongatinib) in patients with HER2 exon20 mutations
2026-02-01 22:25:32
Check Details
Summary and analysis of vosoritide clinical trial data and different indications, efficacy observations and safety studies
2026-02-01 22:25:32
Check Details
The main components of Methylcobalamin Injection (Rozebalamin) and its principle of promoting nerve regeneration
2026-02-01 22:25:32
Check Details
Analysis of the scope of indications and latest clinical applications of the anticancer drug cobimetinib
2026-02-01 22:25:32
Check Details
How effective is macitentan (Aoposu) in treating pulmonary arterial hypertension? Analysis of the latest clinical data
2026-02-01 22:25:32
Check Details
Which type of acute myeloid leukemia is Avonib (Tosovo) mainly used to treat?
2026-02-01 22:25:32
Check Details
Which formal channels can you buy Mitotane tablets in China?
2026-02-01 22:25:32
Check Details
1
2
...
2448
2449
2450
2451
2452
2453
2454
...
10228
10229
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
2
Nintedanib: A Multi-Target Antifibrotic Agent for Slowing Pulmonary Fibrosis Progression
3
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
4
Gilteritinib (XOSPATA): Dosing Cycle, Treatment Duration, and Development Background
5
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
6
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
7
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
8
Valganciclovir (Valcyte) in Post-Transplant CMV Management: A Comprehensive Guide
9
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
10
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
11
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
12
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy